DANSAERT
ActiveSummary
DANSAERT has been active since 1996 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €2.2m and a net result of €718,554. Equity is growing by ~33.5% per year across the filed fiscal years. Its solvency ranks better than 94% of 9620 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.9% (low).
Checked score
Score 2024
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.9%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €190,000 at 30 days acceptable
Liquidity ample (current ratio 7.75 against 5.95 in 2023; short-term debt: 12.3% and cash: 33.6% of total assets), and 12.6% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
87.4%
Return on assets
28.3%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-09-2025, 60 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
60 d late
2023
61 d late
2022
66 d late
2021
75 d late
2020
88 d late
2019
73 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 71 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Is the workforce growing, and do people stay?Employer check
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, abbreviated schema
Equity
€2.2m▲ 48.0%
2023 · €1.5m
Total assets
€2.5m▲ 40.6%
2023 · €1.8m
Net result
€718,554▲ 55.4%
2023 · €462,322
Working capital
€2.1m▲ 53.6%
2023 · €1.4m
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€122,291€460,646▲ 277%€779,017▲ 69.1%€670,490▼ 13.9%€1.0m▲ 51.7%
Net result€83,510€311,900▲ 273%€530,104▲ 70.0%€462,322▼ 12.8%€718,554▲ 55.4%
Equity€554,446▲ 17.7%€866,346▲ 56.3%€1.4m▲ 58.0%€1.5m▲ 9.4%€2.2m▲ 48.0%
Total assets€1.1m▼ 0.6%€1.1m▲ 0.9%€1.8m▲ 63.1%€1.8m▼ 1.4%€2.5m▲ 40.6%
Debt€557,956▼ 13.9%€256,036▼ 54.1%€462,173▲ 80.5%€306,768▼ 33.6%€320,381▲ 4.4%
Working capital€424,146▲ 29.6%€748,699▲ 76.5%€1.3m▲ 69.1%€1.4m▲ 8.0%€2.1m▲ 53.6%
Staff (FTE)3.5▲ 12.9%2.8▼ 20.0%2.5▼ 10.7%2.5=2.4▼ 4.0%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 52% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €2.5m
Fixed assets
€126,390 ▼ 21.8%
Current assets
€2.4m ▲ 46.7%
Equity and liabilities €2.5m
Equity
€2.2m ▲ 48.0%
Debt
€320,381 ▲ 4.4%
Debt's share of the balance-sheet total falls from 17.0% to 12.6%. Equity and debt are higher.
Key figures and ratios
EBITDA
€1.1m▲
2023 · €707,442
Cash flow
€754,936▲
2023 · €499,274
Current ratio
7.75▲
2023 · 5.95
Quick ratio
6.93▲
2023 · 5.07
Debt to equity
0.14▼
2023 · 0.20
ROE
32.4%▲
2023 · 30.9%
ROA
28.3%▲
2023 · 25.6%
Interest coverage
766.66▲
2023 · 325.71
Debt ≤ 1 year
€311,118▲
2023 · €276,163
Debt > 1 year
€6,730▼
2023 · €28,050
Income taxes
€331,521▲
2023 · €214,789
Staff costs
€225,452▲
2023 · €222,882
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | €4,000 | - | - |
| Remuneration, social security and pensions62 | - | €185,001 | €203,655 | €222,882 | €225,452 | ▲ 1.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €55,689 | €48,329 | €45,572 | €36,952 | €36,382 | ▼ 1.5% |
| Other operating charges640/8 | - | €8,024 | €8,357 | €9,753 | €12,287 | ▲ 26.0% |
| Gross operating margin9900 | €382,784 | €702,000 | €1.0m | €940,077 | €1.3m | ▲ 37.3% |
| Operating profit (loss)9901 | €122,291 | €460,646 | €779,017 | €670,490 | €1.0m | ▲ 51.7% |
| Financial income75/76B | - | - | €5 | €8,793 | €34,440 | ▲ 292% |
| Recurring financial income75 | - | - | €5 | €8,793 | €34,440 | ▲ 292% |
| Financial charges65/66B | - | €3,113 | €2,970 | €2,172 | €1,374 | ▼ 36.7% |
| Recurring financial charges65 | €5,237 | €3,113 | €2,970 | €2,172 | €1,374 | ▼ 36.7% |
| Profit (loss) for the period before taxes9903 | €117,054 | €457,533 | €776,052 | €677,111 | €1.1m | ▲ 55.1% |
| Income taxes67/77 | €33,544 | €145,633 | €245,948 | €214,789 | €331,521 | ▲ 54.3% |
| Profit (loss) for the period9904 | €83,510 | €311,900 | €530,104 | €462,322 | €718,554 | ▲ 55.4% |
| Profit (loss) for the period to be appropriated9905 | €83,510 | €311,900 | €530,104 | €462,322 | €718,554 | ▲ 55.4% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.1m | €1.1m | €1.8m | €1.8m | €2.5m | ▲ 40.6% |
| Fixed assets21/28 | €238,439 | €190,110 | €154,441 | €161,536 | €126,390 | ▼ 21.8% |
| Tangible fixed assets22/27 | €213,439 | €165,110 | €129,441 | €136,536 | €100,890 | ▼ 26.1% |
| Land and buildings22 | - | €114,109 | €94,170 | €76,726 | €59,014 | ▼ 23.1% |
| Plant, machinery and equipment23 | - | €35,113 | €29,308 | €20,471 | €12,226 | ▼ 40.3% |
| Furniture and vehicles24 | - | €15,888 | €5,963 | €39,339 | €29,650 | ▼ 24.6% |
| Financial fixed assets28 | €25,000 | €25,000 | €25,000 | €25,000 | €25,500 | ▲ 2.0% |
| Current assets29/58 | €873,963 | €932,272 | €1.7m | €1.6m | €2.4m | ▲ 46.7% |
| Amounts receivable after more than one year29 | - | - | - | - | €940,000 | - |
| Other amounts receivable291 | - | - | - | - | €940,000 | - |
| Stocks and contracts in progress3 | €179,840 | €188,308 | €213,382 | €241,673 | €252,959 | ▲ 4.7% |
| Stocks30/36 | - | €188,308 | €213,382 | €241,673 | €252,959 | ▲ 4.7% |
| Amounts receivable within one year40/41 | €620,120 | €473,097 | €456,968 | €170,521 | €240,560 | ▲ 41.1% |
| Trade receivables40 | - | €107,855 | €107,631 | €121,640 | €169,026 | ▲ 39.0% |
| Other amounts receivable41 | - | €365,242 | €349,337 | €48,881 | €71,534 | ▲ 46.3% |
| Current investments50/53 | - | - | - | €900,000 | - | - |
| Cash at bank and in hand54/58 | €68,690 | €256,971 | €860,728 | €171,684 | €852,521 | ▲ 397% |
| Deferred charges and accrued income490/1 | - | €13,896 | €145,115 | €158,945 | €124,096 | ▼ 21.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.1m | €1.1m | €1.8m | €1.8m | €2.5m | ▲ 40.6% |
| Equity10/15 | €554,446 | €866,346 | €1.4m | €1.5m | €2.2m | ▲ 48.0% |
| Contributions10/11 | - | €335,392 | €335,392 | €18,592 | €18,592 | = |
| Reserves13 | €219,054 | €530,954 | €1.0m | €1.5m | €2.2m | ▲ 48.6% |
| Non-distributable reserves130/1 | - | €19,706 | €19,706 | €19,706 | €19,706 | = |
| Reserves not available under the articles1311 | - | €19,706 | €19,706 | €19,706 | €19,706 | = |
| Tax-exempt reserves132 | - | €25,750 | €25,750 | €25,750 | €25,750 | = |
| Distributable reserves133 | - | €485,498 | €987,613 | €1.4m | €2.2m | ▲ 50.1% |
| Amounts payable17/49 | €557,956 | €256,036 | €462,173 | €306,768 | €320,381 | ▲ 4.4% |
| Amounts payable after more than one year17 | €105,516 | €69,863 | €49,093 | €28,050 | €6,730 | ▼ 76.0% |
| Financial debts170/4 | - | €69,863 | €49,093 | €28,050 | €6,730 | ▼ 76.0% |
| Amounts payable within one year42/48 | €449,817 | €183,573 | €410,490 | €276,163 | €311,118 | ▲ 12.7% |
| Current portion of amounts payable after more than one year42 | - | €37,350 | €22,488 | €22,784 | €23,084 | ▲ 1.3% |
| Trade debts44 | €372,715 | €107,516 | €120,725 | €110,475 | €134,867 | ▲ 22.1% |
| Suppliers440/4 | - | €107,516 | €120,725 | €110,475 | €134,867 | ▲ 22.1% |
| Taxes, remuneration and social security45 | - | €38,527 | €117,262 | €142,424 | €152,957 | ▲ 7.4% |
| Taxes450/3 | - | €14,920 | €90,601 | €113,134 | €133,327 | ▲ 17.8% |
| Remuneration and social security454/9 | - | €23,607 | €26,661 | €29,290 | €19,630 | ▼ 33.0% |
| Other amounts payable47/48 | - | €180 | €150,015 | €480 | €210 | ▼ 56.3% |
| Accrued charges and deferred income492/3 | - | €2,600 | €2,590 | €2,555 | €2,533 | ▼ 0.9% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €83,510 | €311,900 | €530,104 | €462,322 | €718,554 | ▲ 55.4% |
| + Depreciation and write-downs630 | €55,689 | €48,329 | €45,572 | €36,952 | €36,382 | ▼ 1.5% |
| Operating cash flow (approximation) | €139,199 | €360,229 | €575,676 | €499,274 | €754,936 | ▲ 51.2% |
| Investment in fixed assets (approximation) | - | €0 | -€9,903 | -€44,047 | -€1,236 | ▲ 97.2% |
| Change in cash | - | €188,281 | €603,757 | -€689,044 | €680,837 | ▲ 199% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
29-09
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 60 days late
2024
31-12
Financial
Highest result since 2018net €718,554 ▲55.4%
Operating result €1.0m, net result €718,554, both a record.
31-12
Financial
Equity above €2mEq €2.2m ▲48%
5 profitable years in a row build equity to €2.2m.
30-09
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 61 days late
2023
05-10
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 66 days late
2022
31-12
Financial
Equity above €1mEq €1.4m ▲58%
3 profitable years in a row build equity to €1.4m.
14-10
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 75 days late
2021
31-12
Financial
Liquidity triplescurrent ratio 5.08
Current ratio from 1.94 to 5.08; short-term debt falls from €449,817 to €183,573.
27-10
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 88 days late
2020
31-12
Financial
Back to profitnet €83,510
Net result €83,510 after one loss-making year.
31-12
Financial
Equity above €500,000Eq €554,446 ▲17.7%
Equity rises from €470,936 to €554,446.
12-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 73 days late
Show earlier events
2019
31-12
Financial
Weakest financial yearnet -€19,703
Net result drops to -€19,703, the lowest in the series; recovery starts the following year.
30-09
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 61 days late
2018
29-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 29 days late
2017
06-11
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 98 days late
15-02
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 199 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 1996
Ground area
321 m²
Building footprint
205 m²
Volume, LiDAR
4,326 m³
Parcel 21811M0652/00E000, Brussels · tallest building 24.2 m, ±7 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
DANSAERT
since 19962.078.195.108
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21811M0652/00E000 | Brussels | 321 m² | 1 · 205 m² | 24.2 m · 7 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteBrussel2.078.195.108
Similar companies · same sector, comparable size
Remopharma
BE 0806.560.542
Sint-Gillis-Waas · Eq €2,205,160
Philippe Sollie
BE 0406.679.329
Zoersel · Eq €2,198,267
SOLUTIONS AT PHARMACY
BE 0846.333.413
Leuven · Eq €2,190,452
APOTHEEK MIEKE BOUTTELISIER
BE 0456.458.541
Roeselare · Eq €2,257,440
JECO FARMA
BE 0892.081.482
Brakel · Eq €2,262,956
Of 5,220 companies in sector 47730 we hold annual accounts for 3,859. 2,244 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded20-08-1996
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Scores and ratios are computed by Checked and are not a credit decision.